Allergic Rhinitis
📧 Sign up to get email alerts when something new happens for Allergic Rhinitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-11-18Clinical Trial Update: As Needed Versus Regular Intranasal Corticosteroid in Children With Perennial Allergic Rhinitis [Phase 3]
Phase 3 clinical trial comparing as-needed versus regular intranasal corticosteroid dosing in children with perennial allergic rhinitis has …
-
CLINICAL_TRIALS trial_result · 2025-11-14Clinical Trial Update: Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis [Phase 1, Phase 2]
A clinical trial update comparing the pharmacokinetics and pharmacodynamics of FMXIN002 versus EpiPen in healthy adults with allergic rhinit…
-
FDA approval · 2025-10-27FDA Approved: ASTEPRO ALLERGY — Supplemental Application (Bayer HealthCare LLC.)
FDA approved a supplemental application for ASTEPRO ALLERGY (azelastine hydrochloride) from Bayer HealthCare LLC.
-
FDA approval · 2025-10-07FDA Approved: FOSTER AND THRIVE ALLERGY AND CONGESTION D — Original Application (Strategic Sourcing Services LLC)
FDA approved a generic fixed-dose combination product Foster and Thrive Allergy and Congestion D containing fexofenadine hydrochloride and p…
-
CLINICAL_TRIALS trial_result · 2025-10-06Clinical Trial Update: Effectiveness of Probiotics in Relieving Allergic Rhinitis in Children [NA]
A completed clinical trial evaluated the effectiveness of probiotics in relieving allergic rhinitis in children.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2025-10-03Clinical Trial Update: Observational Study of Allergic Rhinitis in Children
An observational study in children with allergic rhinitis conducted by ALK-Abelló A/S has completed.
-
FDA approval · 2025-09-30FDA Approved: MONTELUKAST SODIUM — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved a supplemental application for Montelukast Sodium by Amneal Pharmaceuticals LLC. This approval relates to an updated labeling o…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: Evaluation of the Clinical Efficacy of PURESSENTIEL Allergy Protection Nasal Spray (SNPA®) in House Dust Mite Allergic Rhinitis- ACARAY Study [NA]
The document notes a planned clinical trial evaluating PURESSENTIEL Allergy Protection Nasal Spray (SNPA) for house dust mite–induced allerg…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: Safety and Performance Assessment of the Decongestant Seawater Spray Pocket Valve Enriched With Essential Oils in Patients With Acute Rhinitis Associated With Nasal Obstruction: "DEVALPO" [NA]
Clinical trial update for DEVALPO, a seawater decongestant spray enriched with essential oils, recruiting to assess safety and performance i…
-
CLINICAL_TRIALS trial_result · 2025-09-23Clinical Trial Update: The ARHINASD (Allergic Rhinitis in Pediatric Subjects With Nasal Septum Deviation) Project
This entry reports that the ARHINASD project investigating allergic rhinitis in pediatric subjects with nasal septum deviation has completed…
-
CLINICAL_TRIALS research · 2025-09-17Clinical Trial Update: Nasal Allergen Challenge Test as a Method to Detect Clinical Reactivity Against Birch Pollen [NA]
This clinical trial update describes using a nasal allergen challenge test to detect clinical reactivity to birch pollen.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Tolerability and Potential Efficacy of AD17002 in Subjects With Allergic Rhinitis [Phase 1, Phase 2]
A Phase 1/2 clinical trial update reports on the tolerability and potential efficacy of AD17002 in subjects with allergic rhinitis.
-
CLINICAL_TRIALS trial_result · 2025-09-16Clinical Trial Update: Multimodal Data-assisted Primary Screening for Allergic Rhinitis Based on Voice Recognition and Face Recognition
The clinical trial update reports the completion of a multimodal data-assisted primary screening approach for allergic rhinitis based on voi…
-
FDA label_change · 2025-09-15FDA Approved: FLONASE SENSIMIST ALLERGY RELIEF — Supplemental Application (Haleon US Holdings LLC)
The FDA approved a supplemental application for Flonase Sensimist Allergy Relief (fluticasone furoate nasal spray), under Haleon US Holdings…
-
CLINICAL_TRIALS trial_result · 2025-09-11Clinical Trial Update: Posterior Nasal Nerve Neurectomy for Treatment of Intractable Allergic Rhinitis [NA]
An ongoing clinical trial assessing posterior nasal nerve neurectomy as a treatment for intractable allergic rhinitis, with enrollment curre…
-
CLINICAL_TRIALS trial_result · 2025-09-04Clinical Trial Update: Thread Embedding Acupuncture For Rhinitis Allergy [NA]
Completed clinical trial evaluating thread embedding acupuncture for allergic rhinitis, sponsored by the University of Medicine and Pharmacy…
-
CLINICAL_TRIALS research · 2025-09-04Clinical Trial Update: A Clinical Trial for Evaluation of Efficacy, Safety and Immunogenicity of GNR-127 (Recombinant ABP Antigen Protein Which Carries a Birch Pollen Allergen [BET V 1] and an Apple Allergen [MAL D 1]) in Patients With Birch Pollen Allergic Rhinitis. [Phase 1, Phase 2]
A Phase 1/2 clinical trial evaluating the efficacy, safety, and immunogenicity of GNR-127 (a recombinant ABP antigen carrying birch pollen B…
-
FDA approval · 2025-08-29FDA Approved: CETIRIZINE HYDROCHLORIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for cetirizine hydrochloride from Rising Pharma Holdings, Inc., indicating an update to the approved…
-
CLINICAL_TRIALS trial_result · 2025-08-29Clinical Trial Update: Dietary Supplement (Beta-Glucans) in Allergic Patients Undergoing Subcutaneous Immunotherapy. [Phase 4]
Phase 4 trial evaluating beta-glucans as an adjunct to subcutaneous immunotherapy in allergic rhinitis and asthma patients has completed.
-
FDA approval · 2025-08-22FDA Approved: DIPHENHYDRAMINE HYDROCHLORIDE — Original Application (Micro Labs Limited)
FDA approved a Diphenhydramine hydrochloride product from Micro Labs Limited under Original Application (ANDA 219845). This approval covers …
-
FDA approval · 2025-08-15FDA Approved: FLUTICASONE PROPIONATE — Original Application (Advagen Pharma Ltd.)
FDA approved Advagen Pharma Ltd.'s original application for a generic Fluticasone Propionate nasal spray. The product is indicated for relie…
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Effect of Combined Probiotics and Vitamin D on Symptoms of Allergic Rhinitis [NA]
A clinical trial is examining whether combining probiotics with vitamin D can alleviate symptoms of allergic rhinitis and is currently recru…
-
CLINICAL_TRIALS trial_result · 2025-08-12Clinical Trial Update: Documentation of Efficacy of Intralymphatic Allergen Immunotherapy [Phase 3]
Phase 3 clinical trial has completed and documents the efficacy of intralymphatic allergen immunotherapy for grass pollen–related allergic r…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: A Study on the Efficacy of Environmental Probiotics in Patients With Cat Hair Allergies [NA]
Clinical trial update indicates ongoing enrollment by invitation for a study evaluating environmental probiotics in patients with cat allerg…
-
CLINICAL_TRIALS research · 2025-08-07Clinical Trial Update: Impact of Pet Cats on Nasal and Gut Microbiota in Patients With Cat Allergen Allergy
A clinical trial is recruiting to examine how exposure to cat allergens affects nasal and gut microbiota in people with cat allergen allergy…